| P2093 | author name string | Akihiro Ito | |
| | Yoichi Arai | |
| | Alexander S Baras | |
| | Hiroshi Miyamoto | |
| | Shinichi Yamashita | |
| | Eiji Kashiwagi | |
| | Yuki Teramoto | |
| | Guiyang Jiang | |
| | Takuro Goto | |
| | Yujiro Nagata | |
| P2860 | cites work | Wnt/beta-catenin signaling: components, mechanisms, and diseases | Q24630938 |
| | Inflammation and cancer | Q24649640 |
| | Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression | Q26744754 |
| | Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer | Q27319512 |
| | Estrogen receptor-beta: implications for the prostate gland | Q33674081 |
| | The regulation of β-catenin activity and function in cancer: therapeutic opportunities | Q33779745 |
| | Molecular mechanisms involved in cisplatin cytotoxicity. | Q34058522 |
| | GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens | Q34178465 |
| | Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? | Q34494513 |
| | Roles of ERβ and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen | Q35668841 |
| | Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma | Q35731224 |
| | A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility | Q35970073 |
| | Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma | Q36104764 |
| | Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies | Q36330150 |
| | Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. | Q36454557 |
| | Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer | Q36823607 |
| | Prognostic value of the expression of estrogen receptor β in patients with non-small cell lung cancer: a meta-analysis | Q36874786 |
| | Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals | Q36946642 |
| | Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis | Q36962972 |
| | Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells | Q37207621 |
| | Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer | Q37580192 |
| | Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 |
| | Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma. | Q37960116 |
| | Molecular mechanisms of cisplatin resistance in bladder cancer. | Q37982453 |
| | Role of estrogen receptor β in gynecological cancer | Q38043866 |
| | Signal transduction through beta-catenin and specification of cell fate during embryogenesis | Q38530598 |
| | Estrogen receptor alpha and beta in health and disease | Q38572801 |
| | Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes | Q38582518 |
| | Estrogen receptor β expression and colorectal cancer: a systematic review and meta-analysis | Q38586464 |
| | Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells | Q38739426 |
| | Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3. | Q38775988 |
| | Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. | Q38876950 |
| | Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model | Q38957486 |
| | Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development | Q39073637 |
| | Androgen activates β-catenin signaling in bladder cancer cells | Q39187436 |
| | Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen | Q39246454 |
| | Estrogen receptor α and β in esophageal squamous cell carcinoma | Q39371836 |
| | MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status | Q39518813 |
| | Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells | Q39751974 |
| | Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner | Q40257075 |
| | Investigation of the freely available easy-to-use software 'EZR' for medical statistics | Q41513106 |
| | Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract. | Q41728557 |
| | 17beta-estradiol inhibits prostaglandin E2-induced COX-2 expressions and cell migration by suppressing Akt and ERK1/2 signaling pathways in human LoVo colon cancer cells | Q43072506 |
| | 17-Beta estradiol and hydroxyestradiols interact via the NF-kappa B pathway to elevate cyclooxygenase 2 expression and prostaglandin E2 secretion in human bronchial epithelial cells. | Q46595830 |
| | Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder | Q46766883 |
| | Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer | Q49894728 |
| | Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression. | Q50082353 |
| | Promotion of bladder cancer development and progression by androgen receptor signals. | Q51758123 |
| | Prognostic value of estrogen receptor α and estrogen receptor β in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets. | Q52648133 |
| | Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. | Q54259614 |
| | Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals. | Q54980349 |
| | Updates and novel treatments in urothelial carcinoma | Q57284890 |
| | 17β-Estradiol reduces inflammation and modulates antioxidant enzymes in colonic epithelial cells | Q57804393 |
| | Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma | Q58101135 |
| | Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals | Q59336796 |
| | MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment | Q63633883 |
| | Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder | Q73229757 |
| | Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus | Q80624748 |
| | FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells | Q89593031 |
| | Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma | Q89642775 |
| | Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma | Q90121146 |
| | MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling | Q90386603 |
| | MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells | Q90514105 |
| | Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements? | Q90621120 |
| | WNT/β-catenin signaling in urothelial carcinoma of bladder | Q90784216 |
| | Silencing of estrogen receptor β promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway | Q91139288 |
| | Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer | Q91952024 |
| | Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition | Q92310915 |
| | Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations | Q93607510 |
| P433 | issue | 8 | |
| P304 | page(s) | 2523-2534 | |
| P577 | publication date | 2020-08-01 | |
| P1433 | published in | American Journal of Cancer Research | Q17511667 |
| P1476 | title | Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer | |
| P478 | volume | 10 | |